TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
53.60
-0.34 (-0.63%)
At close: Jun 24, 2026, 4:00 PM EDT
53.47
-0.13 (-0.24%)
After-hours: Jun 24, 2026, 7:47 PM EDT
TG Therapeutics Employees
TG Therapeutics had 399 employees as of December 31, 2025. The number of employees increased by 61 or 18.05% compared to the previous year.
Employees
399
Change
61
Growth
18.05%
Revenue / Employee
$1,755,261
Profits / Employee
$1,157,634
Market Cap
7.60B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 399 | 61 | 18.05% |
| Sep 30, 2025 | 374 | 55 | 17.24% |
| Jun 30, 2025 | 370 | 70 | 23.33% |
| Mar 31, 2025 | 352 | 68 | 23.94% |
| Dec 31, 2024 | 338 | 74 | 28.03% |
| Sep 30, 2024 | 319 | 74 | 30.20% |
| Jun 30, 2024 | 300 | 56 | 22.95% |
| Mar 31, 2024 | 284 | 47 | 19.83% |
| Dec 31, 2023 | 264 | 38 | 16.81% |
| Sep 30, 2023 | 245 | 59 | 31.72% |
| Jun 30, 2023 | 244 | 71 | 41.04% |
| Mar 31, 2023 | 237 | 18 | 8.22% |
| Dec 31, 2022 | 226 | -60 | -20.98% |
| Sep 30, 2022 | 186 | -179 | -49.04% |
| Jun 30, 2022 | 173 | -155 | -47.26% |
| Mar 31, 2022 | 219 | -82 | -27.24% |
| Dec 31, 2021 | 286 | 14 | 5.15% |
| Sep 30, 2021 | 365 | 148 | 68.20% |
| Jun 30, 2021 | 328 | 152 | 86.36% |
| Mar 31, 2021 | 301 | 148 | 96.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 315 |
| Kymera Therapeutics | 253 |
TGTX News
- 2 days ago - TG Therapeutics price target raised to $83 from $57 at Jefferies - TheFly
- 13 days ago - TG Therapeutics Transcript: AGM 2026 - Transcripts
- 15 days ago - TG Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 15 days ago - TG Therapeutics announces Briumvi data, initiates clinical trial - TheFly
- 15 days ago - TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial - GlobeNewsWire
- 21 days ago - TG Therapeutics rises 10.6% - TheFly
- 21 days ago - TG Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 21 days ago - TG Therapeutics announces results from Briumvi trial - TheFly